FDA Approved: LAMOTRIGINE — Supplemental Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approves Alembic Pharmaceuticals Limited's supplemental application for lamotrigine chewable dispersible, expanding the approved generic formulation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Epilepsy

Drugs mentioned

• Lamotrigine Chewable Dispersible (Lamotrigine)

Snippet

SUPPL AP for LAMOTRIGINE (LAMOTRIGINE CHEWABLE DISPERSIBLE)